Cargando…
Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies
Oncolytic viruses (OV) are engineered to infect, replicate in and kill cancer cells. Currently, the OV therapeutic approach is mainly restricted to neoplasia amenable to direct local administration of viral particles, while the possibility of a systemic delivery of cancer-tropic viruses would extend...
Autores principales: | Garofalo, Mariangela, Villa, Alessandro, Rizzi, Nicoletta, Kuryk, Lukasz, Mazzaferro, Vincenzo, Ciana, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213631/ https://www.ncbi.nlm.nih.gov/pubmed/30322158 http://dx.doi.org/10.3390/v10100558 |
Ejemplares similares
-
Heterologous and cross-species tropism of cancer-derived extracellular vesicles
por: Garofalo, Mariangela, et al.
Publicado: (2019) -
Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks
por: Kuryk, Lukasz, et al.
Publicado: (2019) -
Polymer Coated Oncolytic Adenovirus to Selectively Target Hepatocellular Carcinoma Cells
por: Garofalo, Mariangela, et al.
Publicado: (2021) -
Oncolytic adenoviruses coated with MHC-I tumor epitopes for a new oncolytic vaccine platform
por: Capasso, Cristian, et al.
Publicado: (2015) -
Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation
por: Garofalo, Mariangela, et al.
Publicado: (2021)